Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
New breast cancer therapy study findings reported from Tohoku University, Department of Pathology
February 1st, 2007
Research findings, "5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production," are discussed in a new report. According to recent research published in the International Journal of Cancer, "Previous in vitro studies demonstrated that bioactive androgen 5alpha-dihydrotestosterone (DHT) exerted antiproliferative effects through an interaction with androgen receptor (AR) in breast carcinoma cells. However, AR status has not been examined in association with DHT concentration in breast carcinoma tissues, and significance of androgenic actions remains unclear in breast carcinomas." "Therefore, in our study, we first...
Source: Women's Health Weekly (2007-02-01)
|
